Iv, Llcsv Life Sciences Fun... Net Worth

The estimated Net Worth of Iv, Llcsv Life Sciences Fun... is at least $24.8 millier dollars as of 30 July 2014. Iv Fun owns over 715,380 units of Asensus Surgical Inc stock worth over $24,833 and over the last 11 years Iv sold ASXC stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Iv Fun ASXC stock SEC Form 4 insiders trading

Iv has made over 2 trades of the Asensus Surgical Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently Iv bought 715,380 units of ASXC stock worth $9,299,940 on 30 July 2014.

The largest trade Iv's ever made was buying 750,000 units of Asensus Surgical Inc stock on 21 April 2014 worth over $3,000,000. On average, Iv trades about 732,690 units every 50 days since 2014. As of 30 July 2014 Iv still owns at least 71,381 units of Asensus Surgical Inc stock.

You can see the complete history of Iv Fun stock trades at the bottom of the page.

Insiders trading at Asensus Surgical Inc

Over the last 11 years, insiders at Asensus Surgical Inc have traded over $32,677,440 worth of Asensus Surgical Inc stock and bought 7,457,173 units worth $15,992,743 . The most active insiders traders include Jane Ph D Hsiao, Anthony C. J. Fernando et William N Jr Starling. On average, Asensus Surgical Inc executives and independent directors trade stock every 46 days with the average trade being worth of $97,582. The most recent stock trade was executed by Rampertab Shameze on 21 April 2024, trading 81,521 units of ASXC stock currently worth $28,361.

What does Asensus Surgical Inc do?

asensus aps is a computer software company based out of 22a vallensbækvej, brondby, capital region of denmark, denmark.

Complete history of Iv Fun stock trades at Ocular Therapeutix Inc et Asensus Surgical Inc

Asensus Surgical Inc executives and stock owners

Asensus Surgical Inc executives and other stock owners filed with the SEC include:

• Anthony Fernando,
  President, Chief Executive Officer, Director
• Anthony Fernando,
  Pres, CEO & Director
• Shameze Rampertab B.Sc. MBA, CA, CPA,
  Exec. VP & CFO
• Paul LaViolette,
  Independent Chairman of the Board
• Richard Pfenniger,
  Independent Director
• David Milne,
  Independent Director
• William Starling,
  Independent Director
• William Kelley,
  Independent Director
• Jane Hsiao,
  Independent Director
• Andrea Biffi,
  Independent Director
• Shameze Rampertab,
  Chief Financial Officer, Executive Vice President
• Dr. Stephanie M. Fitts,
  VP of Clinical, Quality and Regulatory Affairs
• Amanda Owens,
  Global Head of People
• Paul Ziegler Jr.,
  VP of Sales
• Joshua B. Weingard,
  Chief Legal Officer & Sec.
• Eric A Smith,
  Chief Commercial Officer
• Joseph P Slattery,
  EVP and CFO
• Aftab Kherani,
  Director
• Willam N Kelley,
  Director
• Todd Pope,
  President and CEO
• S.P.A Sofar,,
  10% owner
• Brett Farabaugh,
  Interim CFO
• Capital Iii Lp Aisling Capi...,
  
• Iv, Llcsv Life Sciences Fun...,
  
• Dennis Dougherty,
  Director
• Richard Mueller,
  Chief Operating Officer
• Kevin J Hobert,
  Director
• Elizabeth Kwo,
  Director